Human medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, HIV Infections, Date of authorisation: 10/06/2022, Revision: 14, Status: Authorised

Questions and answers on labelling flexibilities for COVID-19 vaccines

Labelling flexibilities for COVID-19 therapeutics

Veterinary medicines European public assessment report (EPAR): Nobivac Myxo-RHD, live myxoma-vectored rabbit-haemorrhagic-disease virus strain 009, Date of authorisation: 07/09/2011, Revision: 4, Status: Withdrawn

Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms, Date of authorisation: 17/08/2022, Revision: 4, Status: Authorised

Fifth Industry Standing Group (ISG) meeting, European Medicines Agency, Amsterdam, the Netherlands, from 26/06/2023 to 26/06/2023

Fifth European Medicines Agency - EuropaBio bilateral meeting, Virtual meeting, from 06/07/2023 to 06/07/2023

Lamotrigine : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001825/202211

Lamotrigine : List of nationally authorised medicinal products - PSUSA/00001825/202211

Human medicines European public assessment report (EPAR): Ledaga, chlormethine, Mycosis Fungoides, Date of authorisation: 03/03/2017, Revision: 9, Status: Authorised